LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that represents a promising target for the treatment of several metabolic diseases. Administration of recombinant wild type FGF21 to diabetic animals leads to a dramatic improvement in glycaemia and ameliorates other systemic measures of metabolic health. Here we report the pharmaco...
Alternative Titles
Full title
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1369309083
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1369309083
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0065763
